ScholarIQanswers from OpenAlex & ORCID
Longfeng Zhang
ResearcherPublications, citations & collaboration network
Longfeng Zhang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Longfeng Zhang have?
ScholarIQindexed works
Longfeng Zhang has 67 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Longfeng Zhang have?
ScholarIQcitation count
Longfeng Zhang has 577 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Longfeng Zhang?
ScholarIQh-index
Longfeng Zhang has an h-index of 15 in OpenAlex.
What is the i10-index of Longfeng Zhang?
ScholarIQi10-index
Longfeng Zhang has an i10-index of 20 in OpenAlex.
What is the OpenAlex record for Longfeng Zhang?
ScholarIQopenalex
The OpenAlex for Longfeng Zhang is on the source record.
What are the most-cited papers on Longfeng Zhang?
ScholarIQmost cited works
Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China
Hongfu Cai, Longfeng Zhang, Na Li, Shen Chen, Bin Zheng, Jing Yang, Lizhu Weng, Mao-Bai Liu
Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost–effectiveness analysis
Hongfu Cai, Longfeng Zhang, Na Li, Bin Zheng, Maobai Liu
Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways
Ying Chu, Xiaowen Lv, Longfeng Zhang, Xingli Fu, Siwei Song, Airong Su, Deyan Chen, Lianhong Xu, Yongfang Wang, Zhiwei Wu, Zhihua Yun
Vimentin inhibits type I interferon production by disrupting the TBK1-IKKε-IRF3 axis
Hongyang Liu, Guangqiang Ye, Xiaohong Liu, Mengdi Xue, Qiongqiong Zhou, Longfeng Zhang, Kunli Zhang, Li Huang, Changjiang Weng
First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis
Longfeng Zhang, Yongfu Hang, Maobai Liu, Na Li, Hongfu Cai